1131981-32-2
1131981-32-2
Chemical Structure
Glimepiride-d4-2
Synonym(s): Glimperide-d4-2; HOE-490-d4-2
- CAS No.: 1131981-32-2
- Formula:C24H30D4N4O5S
- Molecular Weight:494.64
InChIKey: WIGIZIANZCJQQY-SRGXTAFUSA-N
SMILES: C[C@H](CC1)CC[C@@H]1NC(NS(C(C([2H])=C2[2H])=C([2H])C([2H])=C2CCNC(N3C(C(CC)=C(C3)C)=O)=O)(=O)=O)=O
Biological Activity: Glimepiride-d4-2 (GliAmperide-d4-2) is deuterium labeled Glimepiride. Glimepiride (Glimperide) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Glimepiride-d4-2 | Glimepiride-d4-2 (GliAmperide-d4-2) is deuterium labeled Glimepiride. Glimepiride (Glimperide) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glimepiride (Standard) | 99.74% | Glimepiride (Standard) is the analytical standard of Glimepiride. This product is intended for research and analytical applications. Glimepiride (Glimperide) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glimepiride-d5 | Glimepiride-d5 is the deuterium labeled Glimepiride. Glimepiride (Glimperide) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glimepiride-d8 | Glimepiride-d8 (Glimperide-d8; HOE-490-d8) is deuterium-labeled Glimepiride (HY-B0104). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glimepiride-d4-1 | 99.39% | Glimepiride-d4-1 is deuterium labeled Glimepiride. Glimepiride (Glimperide) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glimepiride-d4 | Glimepiride-d4 is the deuterium labeled Glimepiride. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glimepiride | 99.92% | Glimepiride (Glimperide) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg. Glimepiride acts at ATPase-dependent potassium channels in β cells of the pancreas to stimulate insulin release. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
trans-Hydroxy Glimepiride | trans-hydroxy Glimepiride is an active metabolite of the sulfonylurea Glimepiride (HY-B0104). It is formed from glimepiride primarily in the liver by the cytochrome P450 (CYP) isoform CYP2C9. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
trans-Hydroxy Glimepiride-d4 | trans-Hydroxy Glimepiride-d4 is deuterium labeled trans-Hydroxy Glimepiride. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glimepiride-d4(phenylethyl-α,α,β,β-d4)(cis/trans) | Glimepiride-d4(phenylethyl-α,α,β,β-d4)(cis/trans) is the deuterium labeled . | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glimepiride sulfonamide | 98.0% | Glimepiride sulfonamide acts as both a DPP-IV inhibitor and an α-Amylase inhibitor. It serves as an intermediate for the synthesis of Glimepiride (HY-B0104). Glimepiride sulfonamide stimulates the production and secretion of insulin. It possesses anti-diabetic potential and can be used in diabetes-related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glipizide impurity 12 | Glipizide impurity 12 is an impurity of Glipizide. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glipizide impurity 1 | Glipizide impurity 1 is an impurity of Glipizide. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glimepiride impurity 1 | Glimepiride impurity 1 is an impurity of Glimepiride (HY-B0104). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
